Navigation Links
Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
Date:8/10/2012

THE WOODLANDS, Texas, Aug. 10, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur Sands, M.D., Ph.D., President and Chief Executive Officer, will present at the Wedbush PacGrow 2012 Life Sciences Management Access Conference on Tuesday, August 14th, at 10:55 AM EST in New York City. Dr. Sands will provide an overview of Lexicon's clinical development programs and milestones.

A webcast of the presentation will be available through Lexicon´s website at www.lexpharma.com. An archived version of the presentation will be available at www.lexpharma.com until September 14th, 2012.

About Lexicon
Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease. Lexicon currently has four drug programs in mid-stage development for diabetes, carcinoid syndrome, irritable bowel syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-looking" statements, including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Provide First Quarter 2012 Financial Results
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
4. Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
5. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
6. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
7. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
8. Lexicon to Provide Second Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015  Membership in Medicare ... to a Healthcare Business Strategy report released by ... known as Medigap or Med Supp plans, covered ... 2014, a 5.2% increase from 2013. Between 2013 ... by 551,135 covered lives.  Though UnitedHealth was the ...
(Date:5/6/2015)... 2015  LumiThera Inc., a medical device company focused ... ocular disorders and disease, today announced Retired Congressman ... Board to assist in the company,s mission to treat ... was the U.S. Representative for Washington,s ... He is a member of the Democratic Party. His ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has announced ... Global Strategic Business Report" report to their offering. ... Canada , Japan , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. The global ...
Breaking Medicine Technology:Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... , ABBOTT PARK, Ill., Nov. 12 Nearly one in ... normal and nearly 34 million have low HDL "good" cholesterol ... HDL and trigs, Abbott has launched two Web sites: ... , "Unhealthy high triglyceride and low HDL levels are factors ...
... a leader in fluorescence in vivo imaging from ... new Cat B 750 FAST(TM) imaging agent for ... and therapeutic response in vivo . Cathepsin B ... target in a range of diseases, including atherosclerosis, oncology, and ...
Cached Medicine Technology:New Web Sites Educate About Triglycerides and HDL Cholesterol 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 2VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting 3
(Date:5/7/2015)... Mamaroneck, NY (PRWEB) May 07, 2015 ... 100% natural ingredients, non-GMO, Gluten Free, Vegan, no preservatives, ... lovely handcrafted bottle, this perfumed gift will delight every ... in the US in 2011 and has grown successfully ... traditional soft drinks offers also multiple opportunities as cocktail ...
(Date:5/6/2015)... Device Patent Law Changes:, Six Key Areas of ... 12:30 p.m. EDT, http://www.fdanews.com/DevicePatentLaw , Every year, medical ... claims that waste their time. , It doesn't have ... prevented if devicemakers better understand the trouble spots to watch ... to patent laws from all around the world. , Why ...
(Date:5/6/2015)... 06, 2015 RPS Revolution - a game ... tried and true Rock Paper Scissors game - is now ... that encourage storytelling and easy to learn rules from Rock ... an old favorite. RPS Revolution takes the best ... characters that are grouped in set of three called Trios. ...
(Date:5/6/2015)... Mass. (PRWEB) May 06, 2015 ... today announced that CTO David Ting will lead a ... the associated data security and user authentication challenges, during ... Fla.). The session will focus on the benefits of ... in which care providers and patients can share information. ...
(Date:5/6/2015)... Qushanna Doby (20) was arrested for child neglect, after leaving ... while under the influence of Flakka, according to CBS ... CBS4’s Peter D’Oench records Doby distraught in a parking lot ... year old. The drug treatment center in Florida who found ... residents polled by CBS Miami express concern about the fate ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 2Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 3Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2
... A nano-technology researcher at the Massachusetts Institute of ... faster , better, cheaper and environmentally-friendly transistors, batteries, ... semiconductors for use in modern electrical devices. ... diseases like AIDS, polio, and influenza, and can ...
... in the middle of the night ? You wont have ... Korea. For you will have replacement drivers on call .,Thousands ... people and their cars home. ,,Their work has ... other major cities of South Korea that the national statistical ...
... have identified a new gene mutation that is associated ... is also known as Prick's disease . ... of the brain that control behaviour and language. Language ... symptoms. ,Unlike Alzheimer's disease, this Frontotemporal ...
... has revealed that individuals age 49 and older with ... age-related macular degeneration appear to have higher mortality ... visual impairments. ,Several studies have shown associations ... older individuals. ,"The mechanisms for higher mortality ...
... Z partied so hard that the 'Beautiful Liar' star could not ... of the bottle . ,Last week, the 'Dangerously in ... ,A source said that the 25-year-old said that she did ... glass. ,"Beyonc? said she didn't mind - she didn't ...
... African fish signal their amorous intentions by exchanging bursts of ... ,Scientists describe this behavior as being somewhat similar to ... study, which has been reported by National Geographic, these fish ... ,Until now, the love life of electric ...
Cached Medicine News:Health News:Replacement Drivers Lend a Helping Hand to the Drunk and Stranded in Korea 2Health News:Replacement Drivers Lend a Helping Hand to the Drunk and Stranded in Korea 3Health News:Scientists Identify New Genetic Mutation Behind Common Dementia 2Health News:Visual Impairment Linked to Greater Mortality Risk 2Health News:Amorous African Fish Exchange Electric Pulses While Mating 2
The CryoSurgery console is the control center for CryoCath's surgical probe. It is a modular system made up of a console control unit and a tank dolly system. The system can be used as a unit or in s...
... minimally invasive cryocatheter to treat atrioventricular ... very high level of safety through ... minimal tissue disruption, and minimal risk ... allows physicians to surgically treat cardiac ...
... is a malleable, single-use cryosurgical probe developed ... The probe will ablate cardiac tissue while ... surgical procedure, such as coronary artery bypass ... and/or repair and as part of the ...
... has developed a minimally invasive cryocatheter ... It delivers a very high level ... pinpoint site precision, minimal tissue disruption, ... stenosis., ,Freezor is a flexible, single-use, ...
Medicine Products: